ReviewPsychogeriatrics : the official journal of the Japanese Psychogeriatric Society2026
Recognising Mild Cognitive Impairment and Early Alzheimer's Disease in General and Psychiatric Practice: Clinical Clues and Appropriate Referral.
Review in Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early cognitive decline may become evident through changes in daily activities or behaviour before it is apparent in a brief consultation. This selective narrative review supports case-finding and appropriate referral in general and psychiatric practice. Four actions organise the review: identify decline in previously mastered instrumental activities of daily living; recognise new apathy or sustained behavioural change; use a cognitive screen sensitive to mild impairment, such as the Montreal Cognitive Assessment; and refer when clinically meaningful concern remains. Functional and behavioural findings require interpretation alongside medical, psychiatric and social factors. Mild behavioural impairment has reported associations with both amyloid and tau, varying across populations. Depression, medication exposure or a reassuring screening score should not end the assessment of otherwise unexplained decline. Collateral information strengthens the assessment but living alone and lacking a reliable informant are distinct circumstances. Municipal and care services may contribute observations without resolving every gap. Dementia disease medical centres should coordinate assessment and support with referring clinicians and community services.
Indexed as
Identifiers
42881131What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.